跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-RANITIDINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-RANITIDINE
Authorized
STANDARD
AG-RANITIDINE
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
045546578a4d401e
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
045546578a4d401e
Drug Approval Canada Name
AG-RANITIDINE
Product Name
AG-RANITIDINE
Status
Cancelled Post Market
Status Date
2021-12-03
Original Market Date
2019-08-14
Din
02484501
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.12
Atc Original
A02BA02 RANITIDINE
Atc Name
a 02 ba 02
Aig Number
0115150002
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
RANITIDINE (RANITIDINE HYDROCHLORIDE)
150 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
045546578a4d401e
Type
Standard
Back to Health Canada Approvals